sodium-binding benzofuran isophthalate has been researched along with 3,3'-dipropyl-2,2'-thiadicarbocyanine in 1 studies
Studies (sodium-binding benzofuran isophthalate) | Trials (sodium-binding benzofuran isophthalate) | Recent Studies (post-2010) (sodium-binding benzofuran isophthalate) | Studies (3,3'-dipropyl-2,2'-thiadicarbocyanine) | Trials (3,3'-dipropyl-2,2'-thiadicarbocyanine) | Recent Studies (post-2010) (3,3'-dipropyl-2,2'-thiadicarbocyanine) |
---|---|---|---|---|---|
98 | 0 | 10 | 134 | 0 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avdonin, PV; Cheglakov, IB | 1 |
1 other study(ies) available for sodium-binding benzofuran isophthalate and 3,3'-dipropyl-2,2'-thiadicarbocyanine
Article | Year |
---|---|
[Calcium antagonists nicardipine and verapamil suppress Ca(2+) entry and activate Na(+) entry into platelets].
Topics: Benzofurans; Benzothiazoles; Blood Platelets; Calcium; Calcium Channel Blockers; Carbocyanines; Ethers, Cyclic; Fluorescent Dyes; Humans; In Vitro Techniques; Nicardipine; Sodium; Sodium Channels; Verapamil | 2000 |